Good news: the deadlines, funding amounts, and eligibility requirements for this opportunity remain unchanged. The funder has simply refreshed the program description to emphasize its accelerator-style partnership model and updated the link to the main RFP webpage.
Funder: Crohn's and Colitis Foundation
Due Dates: May 31, 2026 (LOI/Preproposal) | August 14, 2026 (Full Proposal)
Funding Amounts: Up to $450,000 per project per year; potential renewal for an additional $450,000/year if milestones are met; indirect costs capped at 10%.
Summary: Supports companies developing innovative non-surgical therapies for fibrotic complications in IBD, focusing on product-oriented research and clinical translation.
Key Information: LOI/Preproposal is required; only invited applicants may submit a full proposal.